Design and heterologous expression of dengue virus envelope protein (E) peptides and their use for serological diagnosis

Journal of Virological Methods

Volumn 186, Issue 1-2, 2012, Pages 55-61

  Honda, Eduardo R ^a,c   Zanchi, Fernando ^b   Rios, Katiuscia ^e   Lira, Ednaldo ^f   Vieira, Deusilene ^b   da Silva, Luiz H P ^b   De Paula, Sergio O ^d  

^a CEPEM   (Brazil)

^b IPEPATRO   (Brazil)

^c FIMCA   (Brazil)

^d FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^e FEDERAL UNIVERSITY OF AMAZONAS   (Brazil)

^f LACEN RO   (Brazil)

Author keywords

Bioinformatics; Dengue; Diagnosis; Indirect ELISA; Peptides

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PEPTIDE;

ANTIBODY DETECTION; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; DENGUE VIRUS 4; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GOLD STANDARD; HETEROLOGOUS EXPRESSION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PEPTIDES; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; VIRAL ENVELOPE PROTEINS;

DENGUE VIRUS; FLAVIVIRIDAE; PROKARYOTA;

EID: 84869011855     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.08.006     Document Type: Article

References (29)

1. Anonymous WHO-Global Plan to Combat Neglected Tropical Diseases, 2008-2015 2007, World Health Organization, Geneva, Switzerland.
2. Anonymous WHO-Dengue. Guidelines for Diagnosis, Treatment, Prevention and Control 2009, World Health Organization., Geneva, Switzerland.
3. Batra G., Nemani S.K., Tyagi P., Swaminathan S., Khanna N. Evaluation of envelope domain III-based single chimeric tetravalent antigen and monovalent antigen mixtures for the detection of anti-dengue antibodies in human sera. BMC Infectious Diseases 2011, 11:64-76.
4. Chambers T.J., Tsai T.F., Pervikof Y., Monath T.P. Vaccine development against dengue and Japanese encephalitis, report a World Health Organization meeting. Vaccine 1997, 15:1494-1502.
5. Chang A., Parrales M., Jimenez J., Sobieszczyk M., Hammer S., et al. Combining Google Earth and GIS mapping technologies in a dengue surveillance system for developing countries. International Journal of Health Geographics 2009, 8:49-58.
6. Chaturvedi U.C., Shrivastava R., Tripathi R.K., Nagar R. Dengue virus-specific suppressor T cells, current perspectives. FEMS Immunology and Medical Microbiology 2007, 50:285-299.
7. Crill W.D., Chang G.J. Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. Journal of Virology 2004, 78:13975-13986.
8. Duong V., Ly S., Lorn T.P., Tuiskunen A., Ong S., et al. Clinical and virological factors influencing the performance of a NS1 antigen-capture assay and potential use as a marker of dengue disease severity. PLoS Neglected Tropical Diseases 2011, 57:e1244.
9. Emini E.A., Hughes J.V., Perlow D.S., Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. Journal of Virology 1985, 55:836-839.
10. Fry S.R., Meyer M., Semple M.G., Simmons C.P., Sekaran S.D., et al. The diagnostic sensitivity of dengue rapid test assays is significantly enhanced by using a combined antigen and antibody testing approach. PLoS Neglected Tropical Diseases 2011, 56:e1199.
11. Gromowski G.D., Barrett N.D., Barrett A.D. Characterization of dengue virus complex-specific neutralizing epitopes on envelope protein domain III of dengue 2 virus. Journal of Virology 2008, 82:8828-8837.
12. Gubler D.J. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends in Microbiology 2002, 102:100-103.
13. Guzman M.G., Jaenisch T., Gaczkowski R., Ty Hang V.T., Sekaran S.D., et al. Multi-country evaluation of the sensitivity and specificity of two commercially - available NS1 ELISA assays for dengue diagnosis. PLoS Neglected Tropical Diseases 2010, 48:e811.
14. Hunsperger E.A., Yoksan S., Buchy P., Nguyen V.C., Sekaran S.D., Enria D.A., et al. Emerging Infectious Diseases 2009, 15:436-440.
15. Karplus P.A., Schulz G.E. Prediction of chain flexibility in proteins - a tool for the selection of peptide antigens. Naturwissenschafren 1985, 72:212-213.
16. Kyle J.L., Harris E. Global spread and persistence of dengue. Annual Review of Microbiology 2008, 62:71-92.
17. Larsen J.E., Lund O., Nielsen M. Improved method for predicting linear B-cell epitopes. Immunome Research 2006, 2:2.
18. Leitmeyer K.C., Vaughn D.W., Watts D.M., Salas R., Villalobos I., et al. Dengue virus structural differences that correlate with pathogenesis. Journal of Virology 1999, 73:4738-4747.
19. Lindenbach B.D., Rice C.M. Molecular biology on flaviviruses. Advances in Viral Research 2003, 59:23-61.
20. Mazumder R., Hu Z.Z., Vinayaka C.R., Sagripanti J.L., Frost S.D.W., Kosakovsky Pond S.L., Wu C.H. Computational analysis and identification of amino acid sites in dengue E protein relevant to development of diagnostics and vaccines. Virus Genes 2007, 35:175-186.
21. Modis Y., Ogata S., Clements D., Harrison S.C. Variable surface epitopes in the crystal structure of dengue virus type 3 envelope glycoprotein. Journal of Virology 2005, 79:1223-2123.
22. Mohabatkar H. Prediction of epitopes and structural properties of Iranian HPV-16 E6 by bioinformatics methods. Asian Pacific Journal of Cancer Prevention 2007, 8:602-606.
23. Mohabatkar H., Kar S.K. Prediction of exposed domains of envelope glycoprotein in Indian HIV-1 isolates and experimental confirmation of their immunogenicity in humans. Brazilian Journal of Medical and Biological Research 2004, 36:675-681.
24. Morrison A.C., Zielinski-Gutierrez E., Scott T.W., Rosenberg R. Defining challenges and proposing solutions for control of the virus vector Aedes aegypti. PLoS Medicine 2008, 53:e68.
25. Noisakran S., Dechtawewat T., Rinkaewkan P., Puttikhunt C., Kanjanahaluethai A., Kasinrerk W., Sittisombut N., Malasit P. Characterization of dengue virus NS1 stably expressed in 293T cell lines. Journal of Virological Methods 2007, 142:67-80.
26. Parker J.M., Guo D., Hodges R.S. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data, correlation of predicted surface residues with antigenicity and X-ray-derived accessible sites. Biochemistry 1986, 25:5425-5432.
27. Rangel da Silva A.N.M., Nascimento E.J.M., Cordeiro M.T., Gil L.H.V.G., Abath F.G.C., et al. Identification of continuous human B-cell epitopes in the envelope glycoprotein of dengue virus type 3 DENV-3. PLoS ONE 2009, 410:e7425.
28. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Research 1994, 22:4673-4680.
29. Vazquez-Prokopec G.M., Kitron U., Montgomery B., Horne P., Ritchie S.A. Quantifying the spatial dimension of dengue virus epidemic spread within a tropical urban environment. PLoS Neglected Tropical Diseases 2010, 412:e920.